Skip to content
LexBuild

Submission for Review: Survey on Practices and Policies Related to the Treatment of Opioid Use Disorders; Correction

---
identifier: "/us/fr/2019-27709"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Submission for Review: Survey on Practices and Policies Related to the Treatment of Opioid Use Disorders; Correction"
title_number: 0
title_name: "Federal Register"
section_number: "2019-27709"
section_name: "Submission for Review: Survey on Practices and Policies Related to the Treatment of Opioid Use Disorders; Correction"
positive_law: false
currency: "2019-12-26"
last_updated: "2019-12-26"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Executive Office of the President"
document_number: "2019-27709"
document_type: "notice"
publication_date: "2019-12-26"
agencies:
  - "Executive Office of the President"
  - "Office of National Drug Control Policy"
fr_citation: "84 FR 71005"
fr_volume: 84
fr_action: "30-Day Notice and request for comments; correction"
---

#  Submission for Review: Survey on Practices and Policies Related to the Treatment of Opioid Use Disorders; Correction

**AGENCY:**

Office of National Drug Control Policy.

**ACTION:**

30-Day Notice and request for comments; correction

**SUMMARY:**

The Office of National Drug Control Policy published a document in the *Federal Register* on December 12, 2019 concerning the Paperwork Reduction Act; Proposed Collection; Comment Request. The document contained an incorrect address and contact information.

**SUPPLEMENTARY INFORMATION:**

**Correction**

In the *Federal Register* of December 12, 2019 84 FR 67964, correct the *ADDRESSES* caption to read:

**ADDRESSES:**

Interested persons are invited to submit written comments on the proposed information collection to the Office of Information and Regulatory Affairs, Office of Management and Budget, 725 17th Street NW, Washington, DC 20503, Attention: Desk Officer for the Office of National Drug Control Policy or sent via electronic mail to *[email protected]* or faxed to (202) 395-6974.

**Correction**

In the *Federal Register* of December 12, 2019 84 FR 67964, correct the *FOR FURTHER INFORMATION* caption to read:

**FOR FURTHER INFORMATION CONTACT:**

A copy of this ICR, with applicable supporting documentation, may be obtained by contacting the Office of Information and Regulatory Affairs, Office of Management and Budget, 725 17th Street NW, Washington, DC 20503, Attention: Desk Officer for the Office of National Drug Control Policy or sent via electronic mail *[email protected]* or faxed to (202) 395-6974.

Dated: December 18, 2019.

Michael Passante,

Acting General Counsel.